Enanta Pharmaceuticals, Inc. ENTA
10.67 USD -0.32 (-2.91%)
Regular-session close
10.25 -0.42 -3.94%
After hours · Nov 16, 4:00 PM ET
10.63 Day range 11.09
10.05 52-week range 17.15
- YTD
- -32.34%
- 1 year
- -11.53%
News
zacks.com Enanta Pharmaceuticals (ENTA) Reports Q4 Loss, Misses Revenue Estimates Enanta Pharmaceuticals (ENTA) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.83. This compares to a loss of $0.87 per share a year ago.benzinga.com Enanta Pharma Q4 EPS $(0.81) Misses $(0.78) Estimate, Sales $12.868M Miss $14.200M Estimate Enanta Pharma (NASDAQ:ENTA) reported quarterly losses of $(0.81) per share which missed the analyst consensus estimate of $(0.78) by 3.85 percent. This is a 6.9 percent increase over losses of…
benzinga.com Enanta Pharmaceuticals Doses First Patient In Its RESOLVE Phase 2b/3 Clinical Trial Of Zelicapavir In Adults At High Risk Of Severe Outcomes From RSV; Topline Data Expected In 2027 The Phase 2b/3 randomized, double-blind, placebo-controlled, multicenter global trial will evaluate the efficacy and safety of zelicapavir in adult outpatients who test positive for RSV and have had…
